Back to Search
ELENI KARAGIANNIS, DO
DO
Pediatrics Physician
NPI: 1619403920Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
302981-01(NY)
Research & Publications (20)
The IRIS V study: pioglitazone improves systemic chronic inflammation in patients with type 2 diabetes under daily routine conditions.
PMID 18473695·Diabetes Technol Ther·2008
4-observational
Diagnosis of magnetoresponsive aromatic and antiaromatic zones in three-membered rings of d- and f-block elements.
PMID 19499535·J Comput Chem·2010
8-other
Successful switch from insulin therapy to treatment with pioglitazone in type 2 diabetes patients with residual beta-cell function: results from the PioSwitch study.
PMID 19422402·Diabetes Obes Metab·2009
4-observational
Changes in insulin resistance and cardiovascular risk induced by PPARgamma activation have no impact on RBP4 plasma concentrations in nondiabetic patients.
PMID 19224430·Horm Metab Res·2009
2-rct
A peptide derived from type 1 thrombospondin repeat-containing protein WISP-1 inhibits corneal and choroidal neovascularization.
PMID 19279315·Invest Ophthalmol Vis Sci·2009
7-preclinical
Competact, a fixed combination of pioglitazone and metformin, improves metabolic markers in type 2 diabetes patients with insufficient glycemic control by metformin alone--results from a post-marketing surveillance trial under daily routine conditions.
PMID 19459767·Diabetes Technol Ther·2009
4-observational
A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells.
PMID 18780781·Proc Natl Acad Sci U S A·2008
8-other
Effects of pioglitazone and/or simvastatin on low density lipoprotein subfractions in non-diabetic patients with high cardiovascular risk: A sub-analysis from the PIOSTAT study.
PMID 18374336·Atherosclerosis·2008
2-rct
Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines.
PMID 18307172·J Cell Biochem·2008
8-other
Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease.
PMID 17588584·Atherosclerosis·2008
4-observational
Visfatin: a putative biomarker for metabolic syndrome is not influenced by pioglitazone or simvastatin treatment in nondiabetic patients at cardiovascular risk -- results from the PIOSTAT study.
PMID 17952841·Horm Metab Res·2007
2-rct
A biochemical model of matrix metalloproteinase 9 activation and inhibition.
PMID 17848556·J Biol Chem·2007
8-other
Peptides derived from type I thrombospondin repeat-containing proteins of the CCN family inhibit proliferation and migration of endothelial cells.
PMID 17707681·Int J Biochem Cell Biol·2007
8-other
Anti-angiogenic peptides identified in thrombospondin type I domains.
PMID 17531201·Biochem Biophys Res Commun·2007
8-other
Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk--the PIOSTAT Study.
PMID 17379006·Metabolism·2007
2-rct
Identification of novel short peptides derived from the alpha 4, alpha 5, and alpha 6 fibrils of type IV collagen with anti-angiogenic properties.
PMID 17239819·Biochem Biophys Res Commun·2007
8-other
Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.
PMID 17239709·J Am Coll Cardiol·2007
3-trial
Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
PMID 16005020·J Theor Biol·2006
8-other
Aromatic gold and silver "rings": hydrosilver(I) and hydrogold(I) analogues of aromatic hydrocarbons.
PMID 15469289·J Am Chem Soc·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 666 LEXINGTON AVE STE 206
MOUNT KISCO, NY 10549 - Phone
- (914) 666-4742
Quick Facts
- NPI
- 1619403920
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile